title: Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle.
abstract: Crigler-Najjar syndrome is an autosomal recessive disorder with severe unconjugated hyperbilirubinemia due to deficiency of bilirubin UDP-glucuronosyltransferase isozyme 1A1 (UGT1A1) encoded by the UGT1A1 gene. Current therapy relies on phototherapy to prevent life-threatening elevations of serum bilirubin levels, but liver transplantation is the only permanent treatment. Muscle-directed gene therapy has several advantages, including easy and safe access through simple intramuscular injections, and has been investigated in human clinical trials. In this study, we have investigated the efficacy of adeno-associated viral (AAV) vector-mediated muscle-directed gene therapy in the preclinical animal model of Crigler-Najjar syndrome, that is the Gunn rat. Serotype 1 AAV vector expressing rat UGT1A1 under the control of muscle-specific creatine kinase promoter was injected at a dose of 3×10(12) genome copies/kg into the muscles of Gunn rats and resulted in expression of UGT1A1 protein and functionally active enzyme in injected muscles. AAV-injected Gunn rats showed an approximately 50% reduction in serum bilirubin levels as compared with saline-treated controls, and this reduction was sustained for at least 1 year postinjection. Increased excretion of alkali-labile metabolites of bilirubin in bile and urine was detected in AAV-injected animals. High-performance liquid chromatography analysis of bile from AAV-injected Gunn rats showed a metabolite with retention time close to that of bilirubin diglucuronide. Taken together, these data show that clinically relevant and sustained reduction of serum bilirubin levels can be achieved by simple and safe intramuscular injections in Gunn rats. AAV-mediated muscle directed gene therapy has potential for the treatment of patients with Crigler-Najjar syndrome type 1.
authors: Telethon Institute of Genetics and Medicine, 80131 Naples, Italy.
authors: Nunzia
authors: N
authors: Pastore
authors: Edoardo
authors: E
authors: Nusco
authors: Jana
authors: J
authors: Vaníkova
authors: Rosa Maria
authors: RM
authors: Sepe
authors: Francesco
authors: F
authors: Vetrini
authors: Antony
authors: A
authors: McDonagh
authors: Alberto
authors: A
authors: Auricchio
authors: Libor
authors: L
authors: Vitek
authors: Nicola
authors: N
authors: Brunetti-Pierri
mesh_terms: D000818:Animals; D001646:Bile / Q000378:metabolism; D001663:Bilirubin / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D000229:Dependovirus / Q000235:genetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D014453:Glucuronosyltransferase / Q000235:genetics* / Q000627:therapeutic use*; D006801:Humans; D006932:Hyperbilirubinemia / Q000235:genetics / Q000628:therapy*; D007273:Injections, Intramuscular; D007527:Isoenzymes / Q000235:genetics / Q000627:therapeutic use; D018482:Muscle, Skeletal / Q000201:enzymology* / Q000473:pathology; D051381:Rats; D011911:Rats, Gunn; D014018:Tissue Distribution; D014161:Transduction, Genetic; D000099148:UGT1A1 Enzyme
chemical_list: D001663:Bilirubin; D014453:Glucuronosyltransferase; D007527:Isoenzymes; D000099148:UGT1A1 Enzyme